4//SEC Filing
Robbins Andrew R 4
Accession 0000899243-22-003462
CIK 0001622229other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 5:37 PM ET
Size
5.6 KB
Accession
0000899243-22-003462
Insider Transaction Report
Form 4
Robbins Andrews R
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-01-25$4.94/sh+690,000$3,410,808→ 690,000 totalExercise: $7.60Exp: 2032-01-25→ Common Stock (690,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest in equal monthly installments over a four year period.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001590157
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 5:37 PM ET
- Size
- 5.6 KB